Physician profile
Roger E Yim
NPI 1780780049
$2,750.24
in general payments reported to CMS, 2019-2025
16 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $421 · 2021: $750 · 2022: $649 · 2023: $256 · 2024: $156 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.32 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,202.79 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $659.78 | 2019-2024 | Breztri |
| Jazz Pharmaceuticals INC. | $259.92 | 2022-2025 | Xywav |
| Insmed, INC. | $140.76 | 2022-2024 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $104.78 | 2022 | |
| Philips North America LLC | $55.25 | 2019-2025 | Encore |
| Actelion Pharmaceuticals US, INC. | $44.28 | 2022 | |
| United Therapeutics Corporation | $41.50 | 2022-2023 | Tyvaso, Orenitram |
| Baxter Healthcare | $40.34 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Harmony Biosciences LLC | $37.84 | 2025 | |
| Genzyme Corporation | $35.68 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.81 | 2022 | |
| Intuitive Surgical, INC. | $29.71 | 2023 | Da Vinci Surgical System |
| Cook Medical LLC | $25.32 | 2025 | Zilver Ptx |
| Csl Behring | $24.46 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.02 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Yim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.